# A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

> **NCT07428473** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Monash University** · enrollment: 64 (estimated)

## Conditions studied

- Elevated LDL-C and High Cholesterol

## Interventions

- **DRUG:** STX-1150

## Key facts

- **NCT ID:** NCT07428473
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07428473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07428473, "A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07428473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*